Sports Cafe (SCA) Quote

$COEP Coeptis Therapeutics Holdings, Inc. (NASDAQ: $COEP) is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer. https://coeptistx.com/our-science/overview/

I’m not an attorney and don’t care what you do with your dead shares.

This company was liquidated 6 years ago.

R59- IART
https://finance.yahoo.com/news/integra-lifesciences-reports-third-quarter-110300251.html
Made some improvement, and only lowered 2024 by $.03. Hired a new CEO as well. What did you think ?

flipper44
Member Level
Re: starric post# 720190
Sunday, 09/15/2024 6:52:53 PM
In that 64 patient Survax non-randomized trial phase IIa trial, for nGBM, 13% of enrolled patients did not have GBM, and they enrolled more mgmt methylated than unmethylated. Their graphs readil

Don't stoop to their level . On 3 of my
watch list spamming the 💩 out of the boards. Very sad .

And just what, pray tell, may possibly be gained by filing or proceeding with a lawsuit of any kind against BORK? Pleases correct me if I am wrong, but it seems to me that the only person who has anything to gain in such a lawsuit is the lawyer who is paid to file and pursue the lawsuit. Someone

Solid opportunity here!

News out

$IQST - iQSTEL Advances Global Expansion with Strategic Acquisition Agreement to Fully Consolidate SwissLink Carrier AG., Enhancing Telecom Powerhouse Vision #otc #otcmarkets #nasdaq #telecom #communications #consolidation #billion #revenue #corp #airweb

https:

0004 s next. And grey

Brings $37 million in projected annual revenue - Uh Oh!,

https://x.com/iqstel/status/1853424164712968602?s=46

ILST- New CEO has been appointed now

https://www.accesswire.com/938493/international-star-inc-appoints-robert-klein-as-new-ceo

flipper44
Member Level
Re: starric post# 720190
Sunday, 09/15/2024 6:52:53 PM
In that 64 patient Survax non-randomized trial phase IIa trial, for nGBM, 13% of enrolled patients did not have GBM, and they enrolled more mgmt methylated than unmethylated. Their graphs readil

Might not the JAMA word limit (I believe 3000) words) have limited the ability to include individual patient data?

Mark Smith NEVER fails to disappoint!

ASII Nice news out Accredited Solutions, Inc. Announces Strategic Acquisition of GlobeTopper, a $37M Revenue Platform Acquisition to Anchor Fintech Strategy https://finance.yahoo.com/news/accredited-solutions-inc-announces-strategic-130000967.html

Was it not the FDA that mandated that placebo patients who
progressed have the option of receiving DCVax-L after progression?
Not per the trial SAP published in JAMA. Other sources have been inconsistent on this. And LP clearly said it was not an FDA decision, it was needed to enhance

RDAR I'm ready. Buckle up this week!

AAP...$36.25...Advance Auto Parts Announces Closing of Sale of Worldpac to Carlyle

November 04 2024 - 8:00AM
Business Wire

Transaction strengthens balance sheet and liquidity with $1.5 billion of cash proceeds.
Advance to provide an update on strategic pri

Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

https://ir.movano.com/websites/movano/English/1100/press-releases.html

Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Company continues to keep us updated with press and X updates... $ILLR

ASII Nice news out Accredited Solutions, Inc. Announces Strategic Acquisition of GlobeTopper, a $37M Revenue Platform Acquisition to Anchor Fintech Strategy https://finance.yahoo.com/news/accredited-solutions-inc-announces-strategic-130000967.html

Must be super Mega--Waiting to drop the hammer after the open=No Gap